Funding

Brenus Pharma

France · Biotech

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

Visit brenus-pharma.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A€11MAngelor — Role not disclosedBIO JAG — Role not disclosedBpifrance — Role not disclosedCrédit Agricole — Role not disclosedKorea Omega Investment Corp — Role not disclosedNoshaq — Role not disclosedOrsa — Role not disclosedSambrinvest — Role not disclosedUI Investissement — Role not disclosed

Investors

AngelorSeries ABIO JAGSeries ABpifranceSeries ACrédit AgricoleSeries AKorea Omega Investment CorpSeries ANoshaqSeries AOrsaSeries ASambrinvestSeries AUI InvestissementSeries A

Coverage

Jul 20, 2026Brenus Pharma · Series A

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesbrenus-pharma.com ↗